- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07285642
Brain and Peripheral Muscle Oxygenation in Patients With Chronic Obstructive Pulmonary Disease
This interventional study aims to investigate the acute effects of different types of exercise on cerebral and peripheral muscle oxygenation in patients with chronic obstructive pulmonary disease (COPD). Functional near-infrared spectroscopy (fNIRS) and near-infrared spectroscopy (NIRS) will be used simultaneously to measure oxygenation changes in the prefrontal cortex and the vastus lateralis muscle during rest, Stroop task performance, the six-minute walk test, aerobic, strengthening, and breathing exercises.
The study will compare COPD patients and age- and sex-matched healthy controls to determine how brain and muscle oxygenation responses differ between groups and among exercise modalities. The findings are expected to guide the design of safe, individualized pulmonary rehabilitation programs that optimize oxygenation without compromising safety.
Study Overview
Status
Conditions
Detailed Description
Functional near-infrared spectroscopy (fNIRS) and near-infrared spectroscopy (NIRS) allow real-time, non-invasive assessment of tissue oxygenation. Although widely used in neurology and exercise physiology, their application in pulmonary diseases such as COPD remains limited.
This study is designed as a non-randomized controlled, multidisciplinary trial conducted at Yedikule Chest Diseases and Thoracic Surgery Training and Research Hospital, Istanbul. The research team includes specialists in physiotherapy and rehabilitation, pulmonology, and neuroscience.
Participants will undergo a single standardized pulmonary rehabilitation (PR) session comprising three exercise modalities:Aerobic training, Peripheral strengthening exercises and Breathing exercises.
Before and after exercise, participants will perform the Stroop cognitive task to evaluate executive function and its relationship with cerebral oxygenation. Continuous fNIRS and NIRS monitoring will occur at rest, during each exercise, and during recovery.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Esra Pehlivan
- Phone Number: +90216 777 87 77
- Email: esra.pehlivan@sbu.edu.tr
Study Locations
-
-
-
Istanbul, Turkey (Türkiye), 34668
- Recruiting
- Esra Pehlivan
-
Contact:
- Esra Pehlivan
- Phone Number: +90 216 777 8 777
- Email: esra.pehlivan@sbu.edu.tr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria
- Age 40-70 years
- Diagnosis of moderate-to-severe COPD (GOLD stage II-III)
- Stable disease (no exacerbation in previous 4 weeks)
- BMI 18.5-24.9 kg/m²
- Manual muscle strength ≥ 4 (MRC scale)
- Ability to perform exercise tests safely
- Written informed consent
Exclusion Criteria
- Severe comorbid conditions (uncontrolled cardiac, neurological, or orthopedic disease)
- Need for high-flow oxygen therapy (>2 L/min)
- History of cerebrovascular disease or transient ischemic attack
- Musculoskeletal or dermatological conditions impairing NIRS measurement sites
- Restrictive lung disease, interstitial lung disease, or small-airway disease
- Participation in an exercise program within the last 12 months
Healthy Controls
- Age 40-70 years
- No acute or chronic disease
- Non-smoker
- BMI 18.5-24.9 kg/m²
- No musculoskeletal limitations
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Diagnostic
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: COPD
|
Participants perform treadmill walking for 15 minutes at 60% of the heart rate reserve (HRR), following a 2-minute warm-up period.
Exercise intensity is calculated individually using the Karvonen formula.
Continuous oxygenation monitoring is conducted via fNIRS (prefrontal cortex) and NIRS (vastus lateralis).
Participants perform resistance exercises for upper and lower limb major muscle groups using 60% of one-repetition maximum (1RM).
Each exercise consists of 12 repetitions per set, repeated for 15 minutes with 10-second rest intervals between sets.
Movements include shoulder flexion/abduction/extension, hip flexion/abduction/adduction/extension, knee extension, and squatting.
Participants perform controlled breathing exercises including diaphragmatic, chest, and lateral basal breathing techniques.
Each pattern is executed in 10-repetition cycles, repeated for 15 minutes with 10-second rest intervals.
All sessions begin with pursed-lip breathing instruction and are performed in a seated position.
A computerized color-word interference test (PsychoPy software) is administered before and after the exercise session to evaluate executive function and attention.
Performance is analyzed in relation to concurrent fNIRS measurements from the prefrontal cortex.
|
|
Experimental: Healthy Individuals
|
Participants perform treadmill walking for 15 minutes at 60% of the heart rate reserve (HRR), following a 2-minute warm-up period.
Exercise intensity is calculated individually using the Karvonen formula.
Continuous oxygenation monitoring is conducted via fNIRS (prefrontal cortex) and NIRS (vastus lateralis).
Participants perform resistance exercises for upper and lower limb major muscle groups using 60% of one-repetition maximum (1RM).
Each exercise consists of 12 repetitions per set, repeated for 15 minutes with 10-second rest intervals between sets.
Movements include shoulder flexion/abduction/extension, hip flexion/abduction/adduction/extension, knee extension, and squatting.
Participants perform controlled breathing exercises including diaphragmatic, chest, and lateral basal breathing techniques.
Each pattern is executed in 10-repetition cycles, repeated for 15 minutes with 10-second rest intervals.
All sessions begin with pursed-lip breathing instruction and are performed in a seated position.
A computerized color-word interference test (PsychoPy software) is administered before and after the exercise session to evaluate executive function and attention.
Performance is analyzed in relation to concurrent fNIRS measurements from the prefrontal cortex.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in cerebral oxygenation during exercise
Time Frame: Day 1
|
fNIRS device (Artinis Brite Lite, The Netherlands) with 8-channel prefrontal montage, sampling at 10 Hz.
Data analyzed with MATLAB-based Homer3 and NIRS-KIT software.
|
Day 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in peripheral muscle oxygenation
Time Frame: Day 1
|
NIRS device (Moxy, Fortiori Design LLC, Minnesota, USA).
Parameters analyzed include minimum, maximum, and mean SmO₂ and tHb.
|
Day 1
|
|
Cognitive performance (reaction time, accuracy in Stroop task)
Time Frame: Pre-exercise (baseline) and immediately post-exercise (within 5 minutes after final exercise).
|
Cognitive performance measured as reaction time (ms) and accuracy (%) during a computerized Stroop task performed before and after the exercise session.
This reflects acute changes in executive function and attention related to cerebral oxygenation.
|
Pre-exercise (baseline) and immediately post-exercise (within 5 minutes after final exercise).
|
|
Six-Minute Walk Distance (6MWD)
Time Frame: Baseline
|
Functional exercise capacity assessed using the standardized 6-minute walk test according to American Thoracic Society (ATS) guidelines.
Distance covered is recorded in meters.
Test repeated twice to minimize learning effect, and the better result is used for analysis.
|
Baseline
|
|
Perceived Dyspnea (Modified Borg Scale)
Time Frame: Day 1
|
Participant-reported dyspnea level evaluated before and after each exercise modality using the Modified Borg Scale (0-10).
|
Day 1
|
|
Physical Activity Level (IPAQ-Short Form)
Time Frame: Baseline
|
Self-reported physical activity level evaluated using the International Physical Activity Questionnaire - Short Form (IPAQ-SF).
Results expressed in MET-min/week.
|
Baseline
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
- Pathologic Processes
- Chronic Disease
- Disease Attributes
- Respiratory Tract Diseases
- Lung Diseases
- Lung Diseases, Obstructive
- Pathological Conditions, Signs and Symptoms
- Pulmonary Disease, Chronic Obstructive
- Motor Activity
- Movement
- Musculoskeletal Physiological Phenomena
- Musculoskeletal and Neural Physiological Phenomena
- Therapeutics
- Mind-Body Therapies
- Complementary Therapies
- Exercise Movement Techniques
- Physical Therapy Modalities
- Behavioral Disciplines and Activities
- Psychological Tests
- Neuropsychological Tests
- Exercise
- Breathing Exercises
- Stroop Test
Other Study ID Numbers
- fNIRS&Exercise
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Copd
-
University Medical Center GroningenCompleted
-
Ryme Medical, Inc.Not yet recruitingCOPD | Lung Disease, Chronic Obstructive | COPD Patients | COPD Acute Exacerbation | COPD (Chronic Obstructive Pulmonary Disease) | Lung Disease Airways | COPD Exacerbations
-
Insel Gruppe AG, University Hospital BernUniversity Hospital, Geneva; Cantonal Hospital St. Gallen, SwitzerlandNot yet recruiting
-
Istituto Nazionale di Ricovero e Cura per AnzianiRecruiting
-
Bio-Sensing Solutions S.L. (DyCare)Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau; Centre...Recruiting
-
Sir Run Run Shaw HospitalRecruiting
-
The First Affiliated Hospital of Guangzhou Medical...Recruiting
-
Association des Réseaux BronchioliteLaboratoire Système et Matériaux pour la Mécatronique (SYMME)Recruiting
-
Polytechnic Institute of PortoNippon Gases PortugalRecruiting
-
China-Japan Friendship HospitalNot yet recruiting
Clinical Trials on Aerobic Exercise (Treadmill Walking)
-
University of KarachiAdvanced Education & Research CenterNot yet recruiting
-
Cairo UniversityCompleted
-
Charles Drew University of Medicine and ScienceNational Center for Research Resources (NCRR)CompletedObesity | Metabolic Syndrome | Insulin ResistanceUnited States
-
Atlas UniversityCompletedFatigue | Autonomous Nervous SystemTurkey
-
National Defense Medical Center, TaiwanMinistry of Science and Technology, TaiwanRecruitingCardiology | PsychiatryTaiwan
-
Universidade Estadual Paulista Júlio de Mesquita...Completed
-
Faculdade de Ciências Médicas da Santa Casa de...Fundação de Amparo à Pesquisa do Estado de São Paulo; Coordenação de Aperfeiçoamento...CompletedScoliosis | Adolescent ScoliosisBrazil
-
European University Miguel de CervantesHospital Clínico Universitario de ValladolidCompletedPeripheral Arterial Disease | Intermittent ClaudicationSpain
-
Walailak UniversityChulalongkorn UniversityCompletedHealthy Aging | Physical Fitness | Respiratory Function | Core StabilityThailand